Dietary Prevention of Cancer
Dietary Prevention of Cancer
批准号:
7090128
负责人:
Shrikant Anant
金额:
$3.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2006-06-29
关键词:
angiogenesisapoptosisbiological signal transductioncancer preventioncolon neoplasmsepidermal growth factorflavonoidsfood additivesgene expressiongrowth factor receptorslaboratory mousemetalloendopeptidasesneoplasm /cancer invasivenessnutrition aspect of cancerp53 gene /proteinprostaglandinsvascular endothelial growth factors
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Colon Cancer is a leading cause of death in the United States. Accordingly, methods of preventing this disease or discovery of agents that increase effectiveness of existing chemotherapeutic agents would be very beneficial. Our studies and those of others have indicated that dietary curcumin, an active ingredient in the spice turmeric, potently inhibits intestinal tumorigenesis. We have now characterized the mechanisms by which curcumin modulates this function. Proliferation, angiogenesis and tumor invasiveness constitute the major pathways that are necessary for the growth and metastatic potential of cancer. Our preliminary studies show that curcumin inhibits cell proliferation, and tumor angiogenesis and invasiveness, while it enhances spontaneous and chemotherapy-induced apoptosis of tumor cells. The goals of the current project are to determine the mechanistic effects of curcumin on each of theses processes. Specifically, we will determine the effects of curcumin on growth factor-mediated activation of cellular signaling pathways. We will also determine the role of curcumin in signaling mediated by epidermal growth factor and prostaglandins, two molecules that are active in cancer progression. In addition, we will determine the effect of curcumin on the expression and regulation of tumor suppressor protein p53, an important regulator of cell survival. We will examine the effect of curcumin on expression of p53 target genes such as p21 WAF1, BAX. Moreover, we will examine the role of curcumin in the expression of VEGF and related angiogenesis factors as well as matrix metalloproteinases as regulators of tumor invasiveness. We will compare the results obtained in cell culture studies with that observed in mice with defined genetic manipulations. Together these studies should provide insight into the cancer process and how curcumin suppresses the risk and proliferation of colon cancer, and of no less importance, why curcumin is of great value as a food supplement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
6th Annual Midwest Tumor Microenvironment Meeting
-
批准号:10002411
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2020
-
负责人:Shrikant Anant
-
依托单位:
Bitter Melon Component and Colon Cancer Prevention
-
批准号:8796002
-
项目类别:
-
资助金额:$54.47万
-
财政年份:2014
-
负责人:Shrikant Anant
-
依托单位:
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
-
批准号:9198492
-
项目类别:
-
资助金额:$68.87万
-
财政年份:2014
-
负责人:Shrikant Anant
-
依托单位:
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
-
批准号:8627820
-
项目类别:
-
资助金额:$51.17万
-
财政年份:2014
-
负责人:Shrikant Anant
-
依托单位:
Bitter Melon Component and Colon Cancer Prevention
-
批准号:9321795
-
项目类别:
-
资助金额:$54.47万
-
财政年份:2014
-
负责人:Shrikant Anant
-
依托单位:
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
-
批准号:9144740
-
项目类别:
-
资助金额:$62.85万
-
财政年份:2014
-
负责人:Shrikant Anant
-
依托单位:
RNA Binding Proteins in Cancer
-
批准号:8444646
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2009
-
负责人:Shrikant Anant
-
依托单位:
RNA Binding Proteins in Cancer
-
批准号:8245786
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2009
-
负责人:Shrikant Anant
-
依托单位:
RNA Binding Protein CUGBP2 in Intestinal Epithelium
-
批准号:7583130
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2009
-
负责人:Shrikant Anant
-
依托单位:
RNA Binding Protein CUGBP2 in Intestinal Epithelium
-
批准号:7924796
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2009
-
负责人:Shrikant Anant
-
依托单位:
RNA Binding Proteins in Cancer
-
批准号:8018162
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2009
-
负责人:Shrikant Anant
-
依托单位:
RNA Binding Proteins in Cancer
-
批准号:7650663
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2009
-
负责人:Shrikant Anant
-
依托单位:
Dietary Prevention of Cancer
-
批准号:8060578
-
项目类别:
-
资助金额:$24.27万
-
财政年份:2005
-
负责人:Shrikant Anant
-
依托单位:
Dietary Prevention of Cancer
-
批准号:7894816
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2005
-
负责人:Shrikant Anant
-
依托单位:
Dietary Prevention of Cancer
-
批准号:8060000
-
项目类别:
-
资助金额:$8.13万
-
财政年份:2005
-
负责人:Shrikant Anant
-
依托单位:
Dietary Prevention of Cancer
-
批准号:7741082
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2005
-
负责人:Shrikant Anant
-
依托单位:
Dietary Prevention of Cancer
-
批准号:7935733
-
项目类别:
-
资助金额:$5.88万
-
财政年份:2005
-
负责人:Shrikant Anant
-
依托单位:
Dietary Prevention of Cancer
-
批准号:7405370
-
项目类别:
-
资助金额:$27.43万
-
财政年份:2005
-
负责人:Shrikant Anant
-
依托单位:
Dietary Prevention of Cancer
-
批准号:6970345
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2005
-
负责人:Shrikant Anant
-
依托单位:
Dietary Prevention of Cancer
-
批准号:7225535
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2005
-
负责人:Shrikant Anant
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: